OPTIMA: An Open-Label, Non-comparative Pilot Trial of Inhaled Molgramostim in Pulmonary Nontuberculous Mycobacterial Infection.
Rachel M ThomsonMichael R LoebingerAndrew J BurkeLucy C MorganGrant W WatererCecilia GanslandtPublished in: Annals of the American Thoracic Society (2023)
ClinicalTrials.gov No: NCT03421743.